Experts in health data
Redefining personalised care with innovative solutions using rich metabolic data,
enabling healthcare teams to improve patient outcomes.
Our partners
Creating data driven solutions for good
User Experience
We include our users throughout each project, ensuring our solutions are optimised specifically to their needs.
Health Data
Utilising our expertise in metabolic data and methodologies to extract insights and develop algorithms to predict the outcomes of individuals
Implementation
Our extensive technical knowledge and creative thinking means we can implement our solutions despite challenging access barriers
We are on a mission to transform personalised care by using rich, metabolic data to create innovative solutions, enabling healthcare teams to improve patient outcomes.
425 million people are currently diagnosed with
Diabetes
costing $760 billion in 2019
430 million people are currently diagnosed with
Cardiovascular Disease
costing $863 billion in 2010
850 million people are currently diagnosed with
Chronic Kidney Disease
costing $82 billion in 2018 (US only)
Why we’re here
Over 1 billion people have metabolic disease; these progressive, silent diseases are identified too late and account for 33% of deaths globally.
Having a metabolic disease puts someone at higher risk of developing other severe health complications such as cardiovascular disease and chronic kidney disease (CKD), identifying these earlier can:
Reduce cost to healthcare practitioners
Ensure better outcomes for patients, save lives
Featured
We are currently preparing for the first real world implementation of our CKD pre-screening tool
Our solution is a pre-screening algorithm that risk stratifies patients based on those most likely to have an eGFR<60. Our solution is:
Validated globally
Non-invasive - No biochemical testing is required
A minimal resource solution that is created using inputs that are either readily available or easily collected
The team is innovating at a fast pace with a focus on creating solutions with
a meaningful difference to patients and healthcare professionals
Recent updates
Our CKD Screening Prioritizer is a registered medical device.
Our Chronic Kidney Disease Screening Prioritizer (CSP) has
received a UKCA marking and regulatory approval meaning...
2022: A year in Review
2022 was a year full of innovation, resilience, and creativity
Gendius was formed with a mission to help...
Gendius presents at American Society of Nephrology Conference
Diabetes technology innovator Gendius has presented research on its new data-driven tool to identify type-2 diabetes...
